









市場行情
/
股票
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

74.410USD

-6.850-8.43%

收盤 07/16, 16:00（美東）報價延遲15分鐘

5.15B總市值

20.23本益比TTM



Lantheus Holdings Inc

74.410

-6.850-8.43%

概覽公司財務

Lantheus Holdings, Inc. 是一家專注於放射性藥物的公司，致力於提供科學成果，使臨牀醫生能夠發現、對抗和跟蹤疾病，從而爲患者帶來治療效果。該公司的產品分爲三類：放射性藥物腫瘤學、精準診斷和戰略合作伙伴關係。放射性藥物腫瘤學診斷和治療可幫助醫療保健專業人員 (HCP) 發現、對抗和跟蹤癌症，重點是前列腺癌。精準診斷產品可幫助 HCP 發現和跟蹤疾病，重點是心臟病學。戰略合作伙伴關係專注於通過使用生物標誌物解決方案、數字解決方案和放射治療平臺實現精準醫療。其商業產品包括 PYLARIFY、DEFINITY、TechneLite 等。其產品線包括 B 澱粉樣蛋白正電子發射斷層掃描 (PET) 成像劑 NAV-4694，也稱爲 F18-氟呋喃醇。該公司擁有臨牀前資產，特別是 TROP2 和 DUNP19。

公司簡介

公司代碼LNTH

公司名稱Lantheus Holdings Inc

上市日期Jun 25, 2015

成立日期2007

CEOMr. Brian A. Markison

員工數量808

證券類型Ordinary Share

年結日Jun 25

公司地址331 Treble Cove Road

城市NORTH BILLERICA

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編01862

電話19786718001

網址https://www.lantheus.com/

公司代碼LNTH

上市日期Jun 25, 2015

成立日期2007

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Ms. Amanda Morgan

Chief Commercial Officer

39.58K

+55.76%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

收入明細

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

股東統計

更新時間: 5月14日週三

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.27%

The Vanguard Group, Inc.

10.10%

Janus Henderson Investors

9.05%

Farallon Capital Management, L.L.C.

8.71%

State Street Global Advisors (US)

3.81%

Other

57.07%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

53.47%

Investment Advisor

43.79%

Hedge Fund

11.55%

Research Firm

3.19%

Individual Investor

2.27%

Pension Fund

1.94%

Bank and Trust

1.35%

Sovereign Wealth Fund

0.57%

Family Office

0.09%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

1027

81.92M

118.40%

-3.35M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

2023Q1

733

71.94M

105.47%

-6.73M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.79M

11.27%

+17.69K

+0.23%

Mar 31, 2025

The Vanguard Group, Inc.

6.99M

10.1%

-242.63K

-3.36%

Mar 31, 2025

Janus Henderson Investors

6.26M

9.05%

-252.58K

-3.88%

May 30, 2025

Farallon Capital Management, L.L.C.

6.02M

8.71%

+707.00K

+13.30%

Mar 31, 2025

State Street Global Advisors (US)

2.64M

3.81%

-4.26K

-0.16%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.17M

3.14%

+148.84K

+7.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.78M

2.57%

+94.57K

+5.62%

Mar 31, 2025

Westfield Capital Management Company, L.P.

1.59M

2.3%

+34.05K

+2.19%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.41M

2.04%

-96.91K

-6.42%

Mar 31, 2025

Reinhart Partners, LLC

1.21M

1.74%

-160.93K

-11.77%

Mar 31, 2025

持股ETF

更新時間: 7月6日週日

機構名稱

佔比

Harbor Health Care ETF

2.88%

Invesco S&P MidCap 400 GARP ETF

2.64%

Invesco Dorsey Wright Healthcare Momentum ETF

2.28%

SPDR S&P Health Care Equipment ETF

1.83%

Fidelity Stocks for Inflation ETF

1.32%

Janus Henderson US Sustainable Equity ETF

1.26%

Invesco S&P MidCap 400 Pure Growth ETF

1.06%

First Trust Small Cap US Equity Select ETF

Astoria US Quality Kings ETF

0.78%

VictoryShares Free Cash Flow Growth ETF

0.74%

Harbor Health Care ETF

佔比2.88%

Invesco S&P MidCap 400 GARP ETF

佔比2.64%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比2.28%

SPDR S&P Health Care Equipment ETF

佔比1.83%

Fidelity Stocks for Inflation ETF

佔比1.32%

Janus Henderson US Sustainable Equity ETF

佔比1.26%

Invesco S&P MidCap 400 Pure Growth ETF

佔比1.06%

First Trust Small Cap US Equity Select ETF

佔比1%

Astoria US Quality Kings ETF

佔比0.78%

VictoryShares Free Cash Flow Growth ETF

佔比0.74%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

